|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$750
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$1,485
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$35,852
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Targeting PML for therapy in leukemia-initiating cells
|
5R00CA139009-05
|
$241,530
|
$241,530
|
ITO, KEISUKE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Targeting PML for leukemia therapy.
|
5R01CA142874-05
|
$436,776
|
$436,776
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Rapid Testing of Drug Resistant BCR-ABL(+) Leukemia Cells
|
5R44CA153614-03
|
$600,237
|
$600,237
|
RIEDER, RONALD
|
BIOSENSE TECHNOLOGIES, INC.
|
|
Cancer and Leukemia Group B Human Specimen Repositories
|
3U24CA114725-09S1
|
$1,014,550
|
$507,275
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MOLECULAR STUDIES OF BONE MARROW FAILURE
|
5R01CA105312-09
|
$561,426
|
$561,426
|
BESSLER, MONICA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Improved therapeutic approaches for hematological disorder treated with tyrosine
|
5R01CA155091-03
|
$307,951
|
$307,951
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-04
|
$307,951
|
$307,951
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Resistance of CML Stem Cells to Imatinib (Gleevec)
|
5R01CA095684-11
|
$305,276
|
$305,276
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Microenvironmental Regulation of Leukemia Stem Cells
|
5R01CA172447-02
|
$338,142
|
$338,142
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Roles of SIRT1 in normal hematopoietic and leukemic stem cells
|
5R01CA143421-04
|
$304,328
|
$304,328
|
CHEN, WENYONG
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-03
|
$338,142
|
$169,071
|
PFEIFER, GERD
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S1
|
$121,881
|
$7,313
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S2
|
$64,080
|
$3,845
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S3
|
$126,241
|
$7,574
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-31S4
|
$12,600
|
$756
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-31
|
$2,119,061
|
$127,144
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-49S1
|
$118,825
|
$1,188
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-49S2
|
$75,000
|
$750
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-49S3
|
$12,500
|
$125
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-49
|
$10,827,666
|
$108,277
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Molecular Pathways to Thynmic Lymphoma and Leukemia
|
5P01CA109901-10
|
$1,950,256
|
$58,508
|
LOOK, A.
|
DANA-FARBER CANCER INST
|
|
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia
|
1K99CA181488-01
|
$176,720
|
$176,720
|
LOSMAN, JULIE
|
DANA-FARBER CANCER INST
|
|
Prognostic potential of low-level mutations in meylodysplastic syndrome
|
1R21CA175542-01A1
|
$190,313
|
$190,313
|
MAKRIGIORGOS, G.
|
DANA-FARBER CANCER INST
|
|
Evolutionary Dynamics of Brain, Lung, and Hematopoietic Tumors
|
3U54CA143798-05S1
|
$173,000
|
$15,570
|
MICHOR, FRANZISKA
|
DANA-FARBER CANCER INST
|
|
Statistical analysis methods for validating risk prediction models
|
1R21CA185704-01
|
$225,765
|
$112,883
|
UNO, HAJIME
|
DANA-FARBER CANCER INST
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-40S1
|
$74,978
|
$750
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-40
|
$5,552,106
|
$55,521
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Inhibition of Cytochrome c-induced Caspase Activation
|
5R01CA102707-10
|
$255,163
|
$127,582
|
KORNBLUTH, SALLY
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
$101,162
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S6
|
$75,000
|
$750
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S7
|
$122,667
|
$1,227
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Adult Leukemia Research Center
|
5P01CA018029-39
|
$4,098,686
|
$163,947
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-04
|
$170,100
|
$85,050
|
BLEAKLEY, MARIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pathogenic Mechanisms of CSF3R Mutations in Leukemia
|
1K99CA190605-01
|
$80,618
|
$80,618
|
MAXSON, JULIA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Bone Marrow Transplantation for Hematologic Malignancies using Novel Radioimmunot
|
3R01CA138720-05S1
|
$64,750
|
$32,375
|
PRESS, OLIVER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Bone Marrow Transplantation for Hematologic Malignancies using Novel Radioimmunot
|
5R01CA138720-05
|
$343,617
|
$171,809
|
PRESS, OLIVER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
|
5R01CA175215-02
|
$573,794
|
$573,794
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Development of GZ38-1, a Novel Protectant of Chemotherapy-Induced Myelosuppressi
|
4R44CA174074-02
|
$462,399
|
$462,399
|
STRUM, JAY
|
G1 THERAPEUTICS, INC.
|
|
Genetic Analysis of Myeloproliferative Disease
|
2R01CA076167-11
|
$305,269
|
$305,269
|
COWELL, JOHN
|
GEORGIA REGENTS UNIVERSITY
|
|
T cell repertoire of graft-versus-host disease and graft-versus-tumor effects
|
5R01CA154244-10
|
$376,976
|
$376,976
|
KORNGOLD, ROBERT
|
HACKENSACK UNIVERSITY MEDICAL CENTER
|
|
Role of Setbp1 in leukemic stem cell self-renewal
|
5R01CA143193-05
|
$298,713
|
$298,713
|
DU, YANG
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
|
MPD Research Consortium
|
5P01CA108671-08
|
$3,221,226
|
$3,221,226
|
HOFFMAN, RONALD
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis
|
5R01CA134777-04
|
$309,964
|
$309,964
|
CHAN, REBECCA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
2P30CA082709-15
|
$1,559,793
|
$62,392
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-15S1
|
$74,999
|
$3,000
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
No-nonsense approach to treat myeloid malignancies with ASXL1 nonsense mutations
|
1R21CA185751-01
|
$169,650
|
$169,650
|
YANG, FENG-CHUN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
International Symposium on Juvenile Myelomonocytic Leukemia (JMML)
|
5R13CA132568-08
|
$5,000
|
$5,000
|
THOMAS, SANDRA
|
JMML FOUNDATION
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $36,747,316
|